News & Updates

Ablating the gastric fundus to reduce the production of the hunger hormone ghrelin helps women curb their appetite and lose body weight in the ABLATE-WEIGHT first-in-human trial.

In patients with stage II colon cancer, individuals with a right-sided colon cancer (RSCC) appear to have a better prognosis than those with a left-sided colon cancer (LSCC), reveals a recent study. Additionally, adjuvant chemotherapy (ACT) falls short of improving cause-specific survival (CSS) in patients with either RSCC or LSCC.

Use of metoclopramide proves inadequate in enhancing endoscopic visualization among patients with overall active upper gastrointestinal bleeding (UGIB), reports a study. However, it does reduce the need for second look esophagogastroduodenoscopy (EGD).

A 1-day regimen of octreotide infusion, along with endoscopic therapy for variceal bleeding, does not appear to be inferior to the standard 5-day regimen in the prevention of rebleeding and all-cause mortality at 6 weeks, according to the preliminary results of a study.